FDA Authorizes Marketing of Novel Device to Reduce Snoring and Mild Obstructive Sleep Apnea in…
SILBERFEDER, Md., February 5, 2021 / PRNewswire / - Today the US Food and Drug Administration cleared the commercialization of a new prescription device for reducing snoring and mild obstructive sleep apnea. Unlike devices that are used…